Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Dreyer

Showing results (111-120 of 113) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 113 results.
JAMA|May 8, 1996
The Ontario trial of active compression-decompression cardiopulmonary resuscitation for in-hospital and prehospital cardiac arrestI G Stiell, P C Hébert, G A Wells, et al.
Circulation|December 28, 2018
Prospective Validation of the Emergency Heart Failure Mortality Risk Grade for Acute Heart FailureDouglas S Lee, Jacques S Lee, Michael J Schull, et al.
Cancer Immunology Research|April 28, 2021
The Chemokine CX3CL1 Improves Trastuzumab Efficacy in HER2 Low-Expressing Cancer <i>In Vitro</i> and <i>In Vivo</i>Tobias F Dreyer, Sabine Kuhn, Christoph Stange, et al.
Pageof 12

Showing results (111-120 of 113) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 113 results.
JAMA|May 8, 1996
The Ontario trial of active compression-decompression cardiopulmonary resuscitation for in-hospital and prehospital cardiac arrestI G Stiell, P C Hébert, G A Wells, et al.
Circulation|December 28, 2018
Prospective Validation of the Emergency Heart Failure Mortality Risk Grade for Acute Heart FailureDouglas S Lee, Jacques S Lee, Michael J Schull, et al.
Cancer Immunology Research|April 28, 2021
The Chemokine CX3CL1 Improves Trastuzumab Efficacy in HER2 Low-Expressing Cancer <i>In Vitro</i> and <i>In Vivo</i>Tobias F Dreyer, Sabine Kuhn, Christoph Stange, et al.
Pageof 12